Page last updated: 2024-09-04

vatalanib and Carcinoma, Squamous Cell

vatalanib has been researched along with Carcinoma, Squamous Cell in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cordeiro, MM; Dong, Z; Miyazawa, M; Neiva, KG; Nör, JE; Oliveira, DT; Zhang, Z1
Baumann, M; Haberey, M; Hessel, F; Hoinkis, C; Krause, M; Schiefer, Y; Thames, HD; Zips, D1
Baumann, M; Dörfler, A; Eicheler, W; Geyer, P; Haberey, M; Hessel, F; Thames, HD; Zips, D1
Bucana, CD; Carter, KB; Jasser, SA; Kim, S; Myers, JN; Wang, Z; Yazici, YD1

Other Studies

4 other study(ies) available for vatalanib and Carcinoma, Squamous Cell

ArticleYear
Effect of PTK/ZK on the angiogenic switch in head and neck tumors.
    Journal of dental research, 2008, Volume: 87, Issue:12

    Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Coculture Techniques; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Head and Neck Neoplasms; Humans; Interleukin-8; Mice; Mice, SCID; Microvessels; Neoplasm Transplantation; Neovascularization, Pathologic; Phthalazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyridines; Receptors, Vascular Endothelial Growth Factor; Transplantation, Heterologous; Tumor Cells, Cultured

2008
Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice.
    International journal of radiation oncology, biology, physics, 2005, Mar-01, Volume: 61, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Mice, Inbred Strains; Mice, Nude; Phthalazines; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor

2005
Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition.
    Cancer research, 2005, Jun-15, Volume: 65, Issue:12

    Topics: Animals; Blood Vessels; Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypopharyngeal Neoplasms; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Phthalazines; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2005
Antivascular therapy of oral tongue squamous cell carcinoma with PTK787.
    The Laryngoscope, 2005, Volume: 115, Issue:12

    Topics: Animals; Camptothecin; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Therapy, Combination; Follow-Up Studies; In Vitro Techniques; Irinotecan; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Phthalazines; Prodrugs; Protein Kinase Inhibitors; Pyridines; Tongue Neoplasms; Treatment Outcome

2005